Franciscan Research Center

Tacoma, Washington 98405

0 studies enrolling now · 12 studies all time

What they study most

Acute Coronary Syndrome, Anti-coagulation Therapy, Atrial Fibrillation, COPD, Cardiovascular Disease., Colon Cancer, Coronavirus Disease 2019 (COVID-19), DVT, Distal Ulcerative Colitis, Emphysema, Joint Surgery Multiple, Left-sided Ulcerative Colitis

Studies at this site

• A Trial of Vigil for Participants With Ovarian Cancer — Running, not enrolling
• A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection — Stopped early
• Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study — Stopped early
• LVRC IDE Crossover Study (Crossover From IDE Trial CLN0009) — Stopped early
• A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint — Status unconfirmed
• Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema — Completed
• Phase III Acute Coronary Syndrome — Stopped early
• Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN) — Paused
• Access Safety and Efficacy Post Endovascular Intervention — Status unconfirmed
• Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism — Completed
• Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis — Status unconfirmed
• Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism — Completed